Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Cardiology
  - BACK
  - Cardiology
  - Hypercholesterolemia
  - Lp(a)
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - C3 Glomerulopathy
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

expert roundtables

The Evolving Treatment Landscape for Sickle Cell Disease

The Evolving Treatment Landscape for Sickle Cell Disease

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD

Monitoring for the Transition From Nonmetastatic Castration-Resistant Prostate Cancer to Detectable Metastatic Disease

Monitoring for the Transition From Nonmetastatic Castration-Resistant Prostate Cancer to Detectable Metastatic Disease

expert roundtables
By Daniel P. Petrylak, MD; Leonard Gomella, MD

Defining Nonmetastatic Castration-Resistant Prostate Cancer and Weighing the Options for Treatment

Defining Nonmetastatic Castration-Resistant Prostate Cancer and Weighing the Options for Treatment

expert roundtables
By Daniel P. Petrylak, MD; Leonard Gomella, MD

Persistent Challenges and Unmet Needs in Mantle Cell Lymphoma

Persistent Challenges and Unmet Needs in Mantle Cell Lymphoma

expert roundtables
By Anita Kumar, MD; Christopher Flowers, MD, MS; John P. Leonard, MD

Mantle Cell Lymphoma: Advances in Treatment and Prognostication

Mantle Cell Lymphoma: Advances in Treatment and Prognostication

expert roundtables
By Anita Kumar, MD; Christopher Flowers, MD, MS; John P. Leonard, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?